Advanced search
Start date

Liraglutide anti-atrophic mechanisms in an experimental model of Diabetes Mellitus

Grant number: 21/05868-5
Support Opportunities:Scholarships in Brazil - Doctorate
Effective date (Start): October 01, 2021
Effective date (End): February 28, 2025
Field of knowledge:Biological Sciences - Physiology
Principal Investigator:Luiz Carlos Carvalho Navegantes
Grantee:Gabriel Hunzicker Skiba
Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Associated research grant:18/10089-2 - Neural, hormonal and nutritional control of autophagy, AP.TEM


The loss of muscle mass is a consequence of neuromuscular and metabolic diseases and remain untreated. Previous experiments in our laboratory have shown that the Sympathetic Nervous System, by activating the cAMP cascade, positively modulates the protein balance in skeletal muscle by stimulating synthesis and inhibiting proteolytic pathways such as lysosomal/autophagic, dependent on Ca++ and Ubiquitin-Proteasome (UPS). Liraglutide is an analogue of GLP-1 (Glucagon Like Peptide Type I) that stimulates the release of insulin by the pancreas through the induction of cAMP and has been used for the glycemic control of diabetic patients. However, nothing is known about its impact on muscle mass balance. Therefore, the aim of this study will be to investigate the intracellular mechanisms that participate in changes in protein metabolism in skeletal muscle in an experimental model of Diabetes Mellitus treated with Liraglutide. The direct effects of the drug will be studied on C2C12 muscle cells. More specifically, the activities of enzymes and metabolic pathways, gene expression (RtPCR), protein content and levels of protein phosphorylation (Western Blot) related to protein synthesis and proteolysis involved with cAMP signaling will be evaluated. In vivo gene transfection methods will be used to elucidate the role of PKA in the possible anti-atrophic effect of Liraglutide. The understanding of these new mechanisms of action of GLP-1 analogues in the muscle may contribute to the fight against muscular atrophy. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: